Balyasny Asset Management’s Ocular Therapeutix OCUL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.03M | Buy |
218,293
+142,424
| +188% | +$1.32M | ﹤0.01% | 1163 |
|
|
2025
Q1 | $556K | Sell |
75,869
-21,684
| -22% | -$159K | ﹤0.01% | 1546 |
|
|
2024
Q4 | $833K | Buy |
+97,553
| New | +$833K | ﹤0.01% | 1330 |
|
|
2024
Q1 | – | Sell |
-89,000
| Closed | -$397K | – | 2294 |
|
|
2023
Q4 | $397K | Buy |
89,000
+36,656
| +70% | +$163K | ﹤0.01% | 1507 |
|
|
2023
Q3 | $164K | Buy |
52,344
+4,062
| +8% | +$12.8K | ﹤0.01% | 1582 |
|
|
2023
Q2 | $249K | Buy |
48,282
+32,168
| +200% | +$166K | ﹤0.01% | 1640 |
|
|
2023
Q1 | $84.9K | Sell |
16,114
-8,877
| -36% | -$46.8K | ﹤0.01% | 1894 |
|
|
2022
Q4 | $70.2K | Buy |
+24,991
| New | +$70.2K | ﹤0.01% | 1861 |
|
|
2022
Q3 | – | Sell |
-18,459
| Closed | -$74K | – | 2640 |
|
|
2022
Q2 | $74K | Buy |
+18,459
| New | +$74K | ﹤0.01% | 1869 |
|
|
2022
Q1 | – | Sell |
-10,912
| Closed | -$76K | – | 2381 |
|
|
2021
Q4 | $76K | Buy |
+10,912
| New | +$76K | ﹤0.01% | 1773 |
|
|
2021
Q2 | – | Sell |
-16,704
| Closed | -$274K | – | 1947 |
|
|
2021
Q1 | $274K | Buy |
+16,704
| New | +$274K | ﹤0.01% | 1341 |
|
|
2016
Q2 | – | Sell |
-85,000
| Closed | -$821K | – | 1155 |
|
|
2016
Q1 | $821K | Buy |
+85,000
| New | +$821K | ﹤0.01% | 603 |
|